1. Home
  2. FIG vs PEN Comparison

FIG vs PEN Comparison

Compare FIG & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FIG

Figma Inc.

N/A

Current Price

$22.87

Market Cap

11.9B

Sector

Technology

ML Signal

N/A

Logo Penumbra Inc.

PEN

Penumbra Inc.

HOLD

Current Price

$339.30

Market Cap

14.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIG
PEN
Founded
2012
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.9B
14.0B
IPO Year
2025
2015

Fundamental Metrics

Financial Performance
Metric
FIG
PEN
Price
$22.87
$339.30
Analyst Decision
Hold
Buy
Analyst Count
11
18
Target Price
$55.22
$350.94
AVG Volume (30 Days)
13.2M
1.4M
Earning Date
02-18-2026
02-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
367.34
EPS
N/A
4.14
Revenue
$968,957,000.00
$1,333,798,000.00
Revenue This Year
$40.99
$17.03
Revenue Next Year
$23.11
$14.38
P/E Ratio
N/A
$81.99
Revenue Growth
91.92
14.61
52 Week Low
$19.85
$221.26
52 Week High
$142.92
$362.41

Technical Indicators

Market Signals
Indicator
FIG
PEN
Relative Strength Index (RSI) 34.62 50.32
Support Level $21.15 $337.63
Resistance Level $25.17 $340.92
Average True Range (ATR) 1.93 3.40
MACD 0.13 -3.48
Stochastic Oscillator 29.01 7.13

Price Performance

Historical Comparison
FIG
PEN

About FIG Figma Inc.

Figma Inc is engaged in transforming ideas into digital products and experiences. The group focuses on the entire software creation lifecycle, enabling it to quickly launch new products on Figma's browser-based platform and reinforcing its belief that design extends well beyond a single step or role. The company adopts an expansive view, as design is more than how something looks, feels, or works. It derives its revenue from sales of subscriptions for access to its platform.

About PEN Penumbra Inc.

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Share on Social Networks: